close
MENU
5 mins to read

Evil drug CEO raises prices but why all the rage?

What bothers me isn't the price of drugs, it's the rage.
 
Nathan Smith discusses the public's reaction to Daraprim's price rise on NBR Radio and on demand on MyNBR Radio.

Fri, 25 Sep 2015

Some obscure CEO of a peripheral drug company decides to arbitrarily raise the price of a product by 5000% and everybody on the internet flips out. Normal day on the worldwide web? Not really.

Martin Shkreli is the chief executive of Turing Pharmaceuticals, a company internationally condemned for

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Evil drug CEO raises prices but why all the rage?
51871
true